Clinical Trial Update: A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy [Phase 2]

View source ↗

Summary

The document reports the Phase 2 readout for a trial evaluating the safety and efficacy of SPM927 in Painful Diabetic Neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• SPM927

Snippet

Sponsor: UCB Pharma | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: COMPLETED